Saturday 27 January 2024

8 Best Online Psychiatry Services: Cost, Medication Management, and More

 The best online psychiatrists can help people manage mental health conditions with medication. We researched the best options to try in 2024, which include Cerebral, Sesame, and Talkspace.

A quick look at the best online psychiatry services

  • Best for communication options: Talkspace 
  • Best budget-friendly online psychiatry: LiveHealth Online 
  • Best for primary care collaboration: Amwell 
  • Best for evening and weekend appointments: MDLIVE 
  • Best online psychiatrist that takes Medicaid: Doctor On Demand
  • Best psychiatry subscription: Cerebral 
  • Best online psychiatry with no insurance: Sesame 
  • Best psychiatry service with Crisis Care: Brightside Health 

Below, we look at the best psychiatry platforms. We also provide a hands-on review for Cerebral.

Best for communication options: Talkspace

  • Price: $175–$299 without insurance
  • Option to choose psychiatrist: yes
  • Insurance: accepted
Talkspace offers desktop psychiatry sessions and an app for Android and iOS devices. It claims to connect a person with a licensed psychiatrist or psychiatric nurse practitioner in their state within a week.

Talkspace features include:

  • video, phone, and messaging appointments
  • help with anxiety, depression, bipolar disorder, and more
  • 24/7 access to psychiatrists
  • medication management

A person needs to fill out an online assessment before Talkspace matches them with a psychiatry provider. People will consult the same psychiatrist for each session they book unless they decide to change.

People can also access online therapy with Talkspace.

Insurance coverage

Without insurance, an initial appointment costs around $299. Follow-up appointments cost around $175.

Some insurance plans, including Aetna, Cigna, Optum, and Regence, may cover some of the cost of Talkspace appointments. People can also use Health Savings Account (HSA) and Flexible Spending Accounts (FSA) to pay for their sessions. However, the company states its services are unavailable through Medicare or Medicaid.

Source: Medical News Today

Friday 26 January 2024

Sildenafil: Uses, Side Effects, and Where to Buy in 2024

 Sildenafil treats erectile dysfunction (ED) and is the active ingredient in Viagra. We cover sildenafil uses, dosage, and more in this article and feature the best places to buy sildenafil.

This article takes a closer look at sildenafil, ED, including how the drug works to relieve the condition.

  • Best lowcost option: Roman 
  • Best range of ED medication: Hims 
  • Best for local pharmacy pick-up: Optum Perks Online Care 
  • Sildenafil is a popular treatment for ED. Those with this condition have difficulty getting or maintaining an erection. It is a widespread condition, but many people find it difficult to discuss.

    The main ingredient in sildenafil is sildenafil citrate. The inactive ingredients include:

    • microcrystalline cellulose
    • anhydrous dibasic calcium phosphate
    • croscarmellose sodium
    • magnesium stearate
    • hypromellose
    • titanium dioxide
    • lactose
    • triacetin
    • artificial colors

    Viagra is just one brand name option containing sildenafil, and other products might use different inactive ingredients.

    Another brand name medication containing sildenafil is Revatio. In addition to treating ED, Revatio treats pulmonary hypertension.

    A person cannot get sildenafil without a valid prescription from a doctor in the United States.

Sildenafil comes in tablet form and is available in strengths of 25, 50, and 100 milligrams (mg). It also comes in 20 mg doses as the generic form of Revatio, but it does not have Food and Drug Administration (FDA) approval for treating ED.

People generally take a 50 mg sildenafil tablet approximately 1 hourTrusted Source before sex. Regardless of the dose, a person needs to take sildenafil exactly as a doctor recommends and not more than once daily.

Sildenafil is fast-acting, and its effects typically last about 1 hour. However, the drug does not instantaneously produce an erection, and sexual arousal is necessary for the drug to work. Sildenafil also does not affect a person’s sex drive or libido.

Source: Medical News today

Thursday 25 January 2024

In what ways does leukemia affect the body?

 With leukemia, abnormal white blood cells (WBCs) grow and divide uncontrollably, replacing typical WBCs. This can affect many parts of the body, such as blood, bones, and the immune system.

Leukemia is a type of cancer that causes the bone marrow to produce abnormal blood cells. The disease can affect any type of blood cell, but most commonly affects WBCs that help protect against infection and illness.

This article outlines the various ways in which leukemia may affect the body, as well as a person’s day-to-day life. We also describe what leukemia is, including the different types.

How does leukemia affect the blood?

Leukemia leads to the rapid and significant production of abnormal blood cells, typically WBCs.

An excess of abnormal blood cells makes it more difficult for the bone marrow to produce other critical types of blood cells, such as red blood cells and platelets. This lack of red blood cells or platelets can lead to body aches and symptoms of anemia, or severe bruising and bleeding.

A person may experience bone pain as their bone marrow becomes overcrowded by the growth of cancer cells. People most often feel this pain in the long bones of the legs and arms, or in the ribs and sternum.

Sometimes, a person may experience pain due to a mass of cancer cells forming near the nerves of the spinal cord.

Rarely, leukemia may weaken bones to the extent of causing bone fractures. This is more common in weight bearing bones, such as the:

  • pelvis
  • spine
  • thighbone

WBCs play an essentialTrusted Source role in the function of the immune system. They are responsible for fighting infections and diseases in the body.

Leukemia typically affects WBCs, causing the bone marrow to produce abnormal WBCs that cannot fight infections as they should. This impairs the immune system, putting the body at increased risk of developing severe infections and illnesses.

In leukemia, it is possible for cancer cells to infiltrate blood vessels, causing issues such as ischemic cardiac disease, which is also called coronary artery disease (CAD). This is where the heart does not receive an adequate supply of blood and oxygen.

Additionally, certain medications used to treat leukemia may increase the risk of heart failure. Drugs called anthracyclines are the standard therapy for acute types of leukemia. These types progress rapidly, so they require more aggressive treatment. However, receiving high doses of anthracyclines over a short period increases their toxicity.

Muscle weakness is another condition that can affect people with leukemia. Unfortunately, it is often one of the earliest contributorsTrusted Source to poor quality of life in children with leukemia.

Source: Medical News Today

Saturday 20 January 2024

Science confirms it: Love leaves a mark on the brain

 Hop in the car to meet your lover for dinner and a flood of dopamine -- the same hormone underlying cravings for sugar, nicotine and cocaine -- likely infuses your brain's reward center, motivating you to brave the traffic to keep that unique bond alive. But if that dinner is with a mere work acquaintance, that flood might look more like a trickle, suggests new research by CU Boulder neuroscientists.

"What we have found, essentially, is a biological signature of desire that helps us explain why we want to be with some people more than other people," said senior author Zoe Donaldson, associate professor of behavioral neuroscience at CU Boulder.

The study, published Jan. 12 in the journal Current Biology, centers around prairie voles, which have the distinction of being among the 3% to 5% of mammals that form monogamous pair bonds.

Like humans, these fuzzy, wide-eyed rodents tend to couple up long-term, share a home, raise offspring together, and experience something akin to grief when they lose their partner.

By studying them, Donaldson seeks to gain new insight into what goes on inside the human brain to make intimate relationships possible and how we get over it, neurochemically speaking, when those bonds are severed.

The new study gets at both questions, showing for the first time that the neurotransmitter dopamine plays a critical role in keeping love alive.

"As humans, our entire social world is basically defined by different degrees of selective desire to interact with different people, whether it's your romantic partner or your close friends," said Donaldson.

"This research suggests that certain people leave a unique chemical imprint on our brain that drives us to maintain these bonds over time."

How love lights up the brain

For the study, Donaldson and her colleagues used state-of-the art neuroimaging technology to measure, in real time, what happens in the brain as a vole tries to get to its partner.

In one scenario, the vole had to press a lever to open a door to the room where her partner was.

In another, she had to climb over a fence for that reunion.

Meanwhile a tiny fiber-optic sensor tracked activity, millisecond by millisecond, in the animal's nucleus accumbens, a brain region responsible for motivating humans to seek rewarding things, from water and food to drugs of abuse.

(Human neuroimaging studies have shown it is the nucleus accumbens that lights up when we hold our partner's hand.)

Each time the sensor detects a spurt of dopamine, it "lights up like a glow stick," explained first-author Anne Pierce, who worked on the study as a graduate student in Donaldson's lab.

When the voles pushed the lever or climbed over the wall to see their life partner, the fiber "lit up like a rave," she said.

And the party continued as they snuggled and sniffed one another.

In contrast, when a random vole is on the other side of that door or wall, the glow stick dims.

(In a previous study, when dopamine was diminished, she didn't try as hard to reunite, either.)

"This suggests that not only is dopamine really important for motivating us to seek out our partner, but there's actually more dopamine coursing through our reward center when we are with our partner than when we are with a stranger," said Pierce.

Hope for the heartbroken

In another experiment, the vole couple was kept apart for four weeks -- an eternity in the life of a rodent -- and long enough for voles in the wild to find another partner.

When the couple was reunited, they remembered one another, but their signature dopamine surge had almost vanished.

In essence, that fingerprint of desire was gone. As far as their brains were concerned, their former partner was indistinguishable from any other vole.

"We think of this as sort of a reset within the brain that allows the animal to now go on and potentially form a new bond," Donaldson said.

This could be good news for humans who have undergone a painful breakup, or even lost a spouse, suggesting the brain has an inherent mechanism to protect us from endless unrequited love.

The authors stress that more research is necessary to determine how well results in voles translate to their bigger-brained, two-legged counterparts.

But they believe their work could ultimately have important implications for people who either have trouble forming close relationships or those who struggle to get over loss -- a condition known as prolonged grief disorder.

"The hope is that by understanding what healthy bonds look like within the brain, we can begin to identify new therapies to help the many people with mental illnesses that affect their social world," said Donaldson.

Source: ScienceDaily

Friday 19 January 2024

Study reveals function of little-understood synapse in the brain

 New research from Oregon Health & Science University for the first time reveals the function of a little-understood junction between cells in the brain that could have important treatment implications for conditions ranging from multiple sclerosis to Alzheimer's disease, to a type of brain cancer known as glioma.

The study published today in the journal Nature Neuroscience.

Neuroscientists focused on the junction, or synapse, connecting neurons to a non-neuronal cell, known as oligodendrocyte precursor cells, or OPCs.

OPCs can differentiate into oligodendrocytes, which produce a sheath around nerves known as myelin.

Myelin is the protective sheath covering each nerve cell's axon -- the threadlike portion of a cell that transmits electrical signals between cells.

The study found that these synapses play a pivotal role in producing that myelin.

"This is the first investigation of these synapses in live tissue," said senior author Kelly Monk, Ph.D., professor and co-director of the Vollum Institute at OHSU.

"This gives an understanding of the basic, fundamental properties of how these cells work in normal development. In the future, we might look at how they function differently in the context of MS patients."

The fact that these synapses exist at all was the subject of a landmark discovery by OHSU researchers at the Vollum that was published in the journal Nature in May of 2000.

Until that point, synapses in the brain had been known only to carry neurotransmitters between neurons, so the discovery of a synapse between neurons and OPCs came as a revelation.

"After two decades, we still didn't know what these synapses do," Monk said.

Scientists tackled the problem by using single-cell imaging of live tissue in zebrafish, whose transparent bodies enable researchers to see the inner workings of their central nervous system in real time.

Using powerful new tools in imaging, pharmacology and gene editing, researchers were able to use neuron-OPC synapses to predict the timing and location of the formation of myelin.

The findings are likely the tip of the iceberg in terms of understanding the importance of these synapses, said lead author Jiaxing Li, Ph.D., a postdoctoral fellow in Monk's lab.

Oligodendrocyte precursor cells comprise about 5% of all cells in the brain -- meaning the synapses they form with neurons could be relevant to many disease conditions, including the formation of cancerous tumors.

Li noted that previous studies have suggested a role for OPCs in a range of neurodegenerative conditions, including demyelinating disorders such as MS, neurodegenerative diseases such as Alzheimer's and even psychiatric disorders like schizophrenia.

Source: ScienceDaily

Thursday 18 January 2024

NASA analysis confirms 2023 as warmest year on record

 Earth's average surface temperature in 2023 was the warmest on record, according to an analysis by NASA. Global temperatures last year were around 2.1 degrees Fahrenheit (1.2 degrees Celsius) above the average for NASA's baseline period (1951-1980), scientists from NASA's Goddard Institute for Space Studies (GISS) in New York reported.

"NASA and NOAA's global temperature report confirms what billions of people around the world experienced last year; we are facing a climate crisis," said NASA Administrator Bill Nelson. "From extreme heat, to wildfires, to rising sea levels, we can see our Earth is changing. There's still more work to be done, but President Biden and communities across America are taking more action than ever to reduce climate risks and help communities become more resilient -- and NASA will continue to use our vantage point of space to bring critical climate data back down to Earth that is understandable and accessible for all people. NASA and the Biden-Harris Administration are working to protect our home planet and its people, for this generation -- and the next."

In 2023, hundreds of millions of people around the world experienced extreme heat, and each month from June through December set a global record for the respective month. July was the hottest month ever recorded. Overall, Earth was about 2.5 degrees Fahrenheit (or about 1.4 degrees Celsius) warmer in 2023 than the late 19th-century average, when modern record-keeping began.

"The exceptional warming that we're experiencing is not something we've seen before in human history," said Gavin Schmidt, director of GISS. "It's driven primarily by our fossil fuel emissions, and we're seeing the impacts in heat waves, intense rainfall, and coastal flooding."

Though scientists have conclusive evidence that the planet's long-term warming trend is driven by human activity, they still examine other phenomena that can affect yearly or multi-year changes in climate such as El Niño, aerosols and pollution, and volcanic eruptions.

Typically, the largest source of year-to-year variability is the El Niño -- Southern Oscillation ocean climate pattern in the Pacific Ocean. The pattern has two phases -- El Niño and La Niña -- when sea surface temperatures along the equator switch between warmer, average, and cooler temperatures. From 2020-2022, the Pacific Ocean saw three consecutive La Niña events, which tend to cool global temperatures. In May 2023, the ocean transitioned from La Niña to El Niño, which often coincides with the hottest years on record.

However, the record temperatures in the second half of 2023 occurred before the peak of the current El Niño event. Scientists expect to see the biggest impacts of El Niño in February, March, and April.

Scientists have also investigated possible impacts from the January 2022 eruption of the Hunga Tonga-Hunga Ha'apai undersea volcano, which blasted water vapor and fine particles, or aerosols, into the stratosphere. A recent study found that the volcanic aerosols -- by reflecting sunlight away from Earth's surface -- led to an overall slight cooling of less than 0.2 degrees Fahrenheit (or about 0.1 degrees Celsius) in the Southern Hemisphere following the eruption.

"Even with occasional cooling factors like volcanoes or aerosols, we will continue to break records as long as greenhouse gas emissions keep going up," Schmidt said. "And, unfortunately, we just set a new record for greenhouse gas emissions again this past year."

"The record-setting year of 2023 underscores the significance of urgent and continued actions to address climate change," said NASA Deputy Administrator Pam Melroy. "Recent legislation has delivered the U.S. government's largest-ever climate investment, including billions to strengthen America's resilience to the increasing impacts of the climate crisis. As an agency focused on studying our changing climate, NASA's fleet of Earth observing satellites will continue to provide critical data of our home planet at scale to help all people make informed decisions."

Open Science in Action

NASA assembles its temperature record using surface air temperature data collected from tens of thousands of meteorological stations, as well as sea surface temperature data acquired by ship- and buoy-based instruments. This data is analyzed using methods that account for the varied spacing of temperature stations around the globe and for urban heating effects that could skew the calculations.

Independent analyses by NOAA and the Hadley Centre (part of the United Kingdom Met Office) concluded the global surface temperatures for 2023 were the highest since modern record-keeping began. These scientists use much of the same temperature data in their analyses but use different methodologies. Although rankings can differ slightly between the records, they are in broad agreement and show the same ongoing long-term warming in recent decades.

Building on a half century of research, observations, and models, the Biden-Harris Administration including NASA and several federal partners recently launched the U.S. Greenhouse Gas Center to make critical climate data readily available to decisionmakers and citizens. The center supports collaboration across U.S. government agencies and the non-profit and private sectors to make air-, ground-, and space-borne data and resources available online.

Source : ScienceDaily

Wednesday 17 January 2024

Pacific kelp forests are far older that we thought

 The unique underwater kelp forests that line the Pacific Coast support a varied ecosystem that was thought to have evolved along with the kelp over the past 14 million years.

But a new study shows that kelp flourished off the Northwest Coast more than 32 million years ago, long before the appearance of modern groups of marine mammals, sea urchins, birds and bivalves that today call the forests home.

The much greater age of these coastal kelp forests, which today are a rich ecosystem supporting otters, sea lions, seals, and many birds, fish and crustaceans, means that they likely were a main source of food for an ancient, now-extinct mammal called a desmostylian. The hippopotamus-sized grazer is thought to be related to today's sea cows, manatees and their terrestrial relatives, the elephants.

"People initially said, "We don't think the kelps were there before 14 million years ago because the organisms associated with the modern kelp forest were not there yet,'" said paleobotanist Cindy Looy, professor of integrative biology at the University of California, Berkeley. "Now, we show the kelps were there, it's just that all the organisms that you expect to be associated with them were not. Which is not that strange, because you first need the foundation for the whole system before everything else can show up."

Evidence for the greater antiquity of kelp forests, reported this week in the journal Proceedings of the National Academy of Sciences, comes from newly discovered fossils of the kelp's holdfast -- the root-like part of the kelp that anchors it to rocks or rock-bound organisms on the seafloor. The stipe, or stem, attaches to the holdfast and supports the blades, which typically float in the water, thanks to air bladders.

Looy's colleague, Steffen Kiel, dated these fossilized holdfasts, which still grasp clams and envelop barnacles and snails, to 32.1 million years ago, in the middle of the Cenozoic Era, which stretches from 66 million years ago to the present. The oldest previously known kelp fossil, consisting of one air bladder and a blade similar to that of today's bull kelp, dates from 14 million years ago and is in the collection of the University of California Museum of Paleontology (UCMP).

"Our holdfasts provide good evidence for kelp being the food source for an enigmatic group of marine mammals, the desmostylia," said Kiel, lead author of the paper and a senior curator at the Swedish Museum of Natural History in Stockholm. "This is the only order of Cenozoic mammals that actually went extinct during the Cenozoic. Kelp had long been suggested as a food source for these hippo-sized marine mammals, but actual evidence was lacking. Our holdfasts indicate that kelp is a likely candidate."

According to Kiel and Looy, who is the senior author of the paper and UCMP curator of paleobotany, these early kelp forests were likely not as complex as the forests that evolved by about 14 million years ago. Fossils from the late Cenozoic along the Pacific Coast indicate an abundance of bivalves -- clams, oysters and mussels -- birds and sea mammals, including sirenians related to manatees and extinct, bear-like predecessors of the sea otter, called Kolponomos. Such diversity is not found in the fossil record from 32 million years ago.

"Another implication is that the fossil record has, once again, shown that the evolution of life -- in this case, of kelp forests -- was more complex than estimated from biological data alone," Kiel said. "The fossil record shows that numerous animals appeared in, and disappeared from, kelp forests during the past 32 million years, and that the kelp forest ecosystems that we know today have only evolved during the past few million years."

The value of fossil hunting amateurs

The fossils were discovered by James Goedert, an amateur fossil collector who has worked with Kiel in the past. When Goedert broke open four stone nodules he found along the beach near Jansen Creek on the Olympic Peninsula in Washington, he saw what looked like the holdfasts of kelp and other macroalgae common along the coast today.

Kiel, who specializes in invertebrate evolution, agreed and subsequently dated the rocks based on the ratio of strontium isotopes. He also analyzed oxygen isotope levels in the bivalve shells to determine that the holdfasts lived in slightly warmer water than today, at the upper range of temperatures found in modern kelp forests.

Looy reached out to co-author Dula Parkinson, a staff scientist with the Advanced Light Source at Lawrence Berkeley National Laboratory, for help obtaining a 3D X-ray scan of one of the holdfast fossils using Synchrotron Radiation X-ray Tomographic Microscopy (SRXTM). When she reviewed the detailed X-ray slices through the fossil, she was amazed to see a barnacle, a snail, a mussel and tiny, single-celled foraminifera hidden within the holdfast, in addition to the bivalve on which it sat.

Looy noted, however, that the diversity of invertebrates found within the 32-million-year-old fossilized holdfast was not as high as would be found inside a kelp holdfast today.

Source : ScienceDaily

Tuesday 16 January 2024

NASA's Webb discovers dusty 'cat's tail' in Beta Pictoris System

 Beta Pictoris, a young planetary system located just 63 light-years away, continues to intrigue scientists even after decades of in-depth study. It possesses the first dust disk imaged around another star — a disk of debris produced by collisions between asteroids, comets, and planetesimals. Observations from NASA’s Hubble Space Telescope revealed a second debris disk in this system, inclined with respect to the outer disk, which was seen first. Now, a team of astronomers using NASA’s James Webb Space Telescope to image the Beta Pictoris system (Beta Pic) has discovered a new, previously unseen structure.

The team, led by Isabel Rebollido of the Astrobiology Center in Spain, used Webb’s NIRCam (Near-Infrared Camera) and MIRI (Mid-Infrared Instrument) to investigate the composition of Beta Pic’s previously detected main and secondary debris disks. The results exceeded their expectations, revealing a sharply inclined branch of dust, shaped like a cat’s tail, that extends from the southwest portion of the secondary debris disk.

“Beta Pictoris is the debris disk that has it all: It has a really bright, close star that we can study very well, and a complex cirumstellar environment with a multi-component disk, exocomets, and two imaged exoplanets,” said Rebollido, lead author of the study. “While there have been previous observations from the ground in this wavelength range, they did not have the sensitivity and the spatial resolution that we now have with Webb, so they didn’t detect this feature.”

A Star’s Portrait Improved with Webb

Even with Webb or JWST, peering at Beta Pic in the right wavelength range — in this case, the mid-infrared — was crucial to detect the cat’s tail, as it only appeared in the MIRI data. Webb’s mid-infrared data also revealed differences in temperature between Beta Pic’s two disks, which likely is due to differences in composition.

“We didn’t expect Webb to reveal that there are two different types of material around Beta Pic, but MIRI clearly showed us that the material of the secondary disk and cat’s tail is hotter than the main disk,” said Christopher Stark, a co-author of the study at NASA’s Goddard Space Flight Center in Greenbelt, Maryland. “The dust that forms that disk and tail must be very dark, so we don’t easily see it at visible wavelengths — but in the mid-infrared, it’s glowing.”

To explain the hotter temperature, the team deduced that the dust may be highly porous “organic refractory material,” similar to the matter found on the surfaces of comets and asteroids in our solar system. For example, a preliminary analysis of material sampled from asteroid Bennu by NASA’s OSIRIS-REx mission found it to be very dark and carbon-rich, much like what MIRI detected at Beta Pic.

The Tail’s Puzzling Beginning Warrants Future Research

However, a major lingering question remains: What could explain the shape of the cat’s tail, a uniquely curved feature unlike what is seen in disks around other stars?

Rebollido and the team modeled various scenarios in an attempt to emulate the cat’s tail and unravel its origins. Though further research and testing is required, the team presents a strong hypothesis that the cat’s tail is the result of a dust production event that occurred a mere one hundred years ago.

“Something happens — like a collision — and a lot of dust is produced,” shared Marshall Perrin, a co-author of the study at the Space Telescope Science Institute in Baltimore, Maryland. “At first, the dust goes in the same orbital direction as its source, but then it also starts to spread out. The light from the star pushes the smallest, fluffiest dust particles away from the star faster, while the bigger grains do not move as much, creating a long tendril of dust.”

“The cat’s tail feature is highly unusual, and reproducing the curvature with a dynamical model was difficult,” explained Stark. “Our model requires dust that can be pushed out of the system extremely rapidly, which again suggests it’s made of organic refractory material.”

The team’s preferred model explains the sharp angle of the tail away from the disk as a simple optical illusion. Our perspective combined with the curved shape of the tail creates the observed angle of the tail, while in fact, the arc of material is only departing from the disk at a five-degree incline. Taking into consideration the tail’s brightness, the team estimates the amount of dust within the cat’s tail to be equivalent to a large main belt asteroid spread out across 10 billion miles.

A recent dust production event within Beta Pic’s debris disks could also explain a newly-seen asymmetric extension of the inclined inner disk, as shown in the MIRI data and seen only on the side opposite of the tail. Recent collisional dust production could also account for a feature previously spotted by the Atacama Large Millimeter/submillimeter Array in 2014: a clump of carbon monoxide (CO) located near the cat’s tail. Since the star’s radiation should break down CO within roughly one hundred years, this still-present concentration of gas could be lingering evidence of the same event.

“Our research suggests that Beta Pic may be even more active and chaotic than we had previously thought,” said Stark. “JWST continues to surprise us, even when looking at the most well-studied objects. We have a completely new window into these planetary systems.”

Source: ScienceDaily

Monday 15 January 2024

Researchers create light-powered yeast, providing insights into evolution, biofuels, cellular aging

 You may be familiar with yeast as the organism content to turn carbs into products like bread and beer when left to ferment in the dark. In these cases, exposure to light can hinder or even spoil the process.

In a new study published in Current Biology, researchers in Georgia Tech's School of Biological Sciences have engineered one of the world's first strains of yeast that may be happier with the lights on.

"We were frankly shocked by how simple it was to turn the yeast into phototrophs (organisms that can harness and use energy from light)," says Anthony Burnetti, a research scientist working in Associate Professor William Ratcliff's laboratory and corresponding author of the study. "All we needed to do was move a single gene, and they grew 2% faster in the light than in the dark. Without any fine-tuning or careful coaxing, it just worked."

Easily equipping the yeast with such an evolutionarily important trait could mean big things for our understanding of how this trait originated -- and how it can be used to study things like biofuel production, evolution, and cellular aging.

Looking for an energy boost

The research was inspired by the group's past work investigating the evolution of multicellular life. The group published their first report on their Multicellularity Long-Term Evolution Experiment (MuLTEE) in Nature last year, uncovering how their single-celled model organism, "snowflake yeast," was able to evolve multicellularity over 3,000 generations.

Throughout these evolution experiments, one major limitation for multicellular evolution appeared: energy.

"Oxygen has a hard time diffusing deep into tissues, and you get tissues without the ability to get energy as a result," says Burnetti. "I was looking for ways to get around this oxygen-based energy limitation."

One way to give organisms an energy boost without using oxygen is through light. But the ability to turn light into usable energy can be complicated from an evolutionary standpoint. For example, the molecular machinery that allows plants to use light for energy involves a host of genes and proteins that are hard to synthesize and transfer to other organisms -- both in the lab and naturally through evolution.

Luckily, plants are not the only organisms that can convert light to energy.

Keeping it simple

A simpler way for organisms to use light is with rhodopsins: proteins that can convert light into energy without additional cellular machinery.

"Rhodopsins are found all over the tree of life and apparently are acquired by organisms obtaining genes from each other over evolutionary time," says Autumn Peterson, a biology Ph.D. student working with Ratcliff and lead author of the study.

Source: ScienceDaily

Sunday 14 January 2024

Transparent brain implant can read deep neural activity from the surface

 Researchers at the University of California San Diego have developed a neural implant that provides information about activity deep inside the brain while sitting on its surface. The implant is made up of a thin, transparent and flexible polymer strip that is packed with a dense array of graphene electrodes. The technology, tested in transgenic mice, brings the researchers a step closer to building a minimally invasive brain-computer interface (BCI) that provides high-resolution data about deep neural activity by using recordings from the brain surface.

The work was published on Jan. 11 in Nature Nanotechnology.

"We are expanding the spatial reach of neural recordings with this technology," said study senior author Duygu Kuzum, a professor in the Department of Electrical and Computer Engineering at the UC San Diego Jacobs School of Engineering. "Even though our implant resides on the brain's surface, its design goes beyond the limits of physical sensing in that it can infer neural activity from deeper layers."

This work overcomes the limitations of current neural implant technologies. Existing surface arrays, for example, are minimally invasive, but they lack the ability to capture information beyond the brain's outer layers. In contrast, electrode arrays with thin needles that penetrate the brain are capable of probing deeper layers, but they often lead to inflammation and scarring, compromising signal quality over time.

The new neural implant developed at UC San Diego offers the best of both worlds.

The implant is a thin, transparent and flexible polymer strip that conforms to the brain's surface. The strip is embedded with a high-density array of tiny, circular graphene electrodes, each measuring 20 micrometers in diameter. Each electrode is connected by a micrometers-thin graphene wire to a circuit board.

In tests on transgenic mice, the implant enabled the researchers to capture high-resolution information about two types of neural activity-electrical activity and calcium activity-at the same time. When placed on the surface of the brain, the implant recorded electrical signals from neurons in the outer layers. At the same time, the researchers used a two-photon microscope to shine laser light through the implant to image calcium spikes from neurons located as deep as 250 micrometers below the surface. The researchers found a correlation between surface electrical signals and calcium spikes in deeper layers. This correlation enabled the researchers to use surface electrical signals to train neural networks to predict calcium activity -- not only for large populations of neurons, but also individual neurons -- at various depths.

"The neural network model is trained to learn the relationship between the surface electrical recordings and the calcium ion activity of the neurons at depth," said Kuzum. "Once it learns that relationship, we can use the model to predict the depth activity from the surface."

Source: ScienceDaily

Sunday 7 January 2024

What is Parkinsonism?

 Parkinsonism is a condition that occurs when a person has symptoms and brain dysfunction commonly associated with Parkinson’s disease but also has other symptoms related to an additional condition or cause.

A person who has Parkinsonism will also have another disorder that causes additional neurological symptoms, ranging from dementia to the inability to look up and down.

Parkinson’s disease itself refers to dysfunction and cell death of the portion of the brain that produces dopamine. Dopamine is a neurotransmitter — a chemical that transmits signals between brain and nerve cells. It is partially responsible for making controlled movements in the body.

In this article, we take a look at the symptoms of Parkinsonism, how the disease is diagnosed, and what can be done to treat it.

Fast facts on Parkinsonism:

  • Doctors call this disease Parkinsonism plus or atypical Parkinsonism.
  • When a person has Parkinson’s disease, their movements are significantly affected.
  • In the disease’s later stages, a person will have difficulty walking and have very stiff, spastic muscles.
  • Treatment will aim to reduce Parkinson’s symptoms while also treating the accompanying disorder.

A person with Parkinsonism usually starts developing symptoms at anywhere from age 50 to 80, according to the University of Texas Southwestern Medical Center.

Parkinson’s disease can cause varying and progressive symptoms throughout its course. Some of the most common symptoms associated with the disease include:

  • difficulty showing facial expressions
  • muscle stiffness
  • slowed, affected movements
  • speech changes
  • tremor, especially of one hand

A person with Parkinsonism may have some, but not all, of the symptoms listed above. This is because they also have an additional disorder that affects the brain’s functioning.

For example, people with Parkinsonism often do not have the hand tremor that affects many people with Parkinson’s disease.

Other symptoms associated with Parkinsonism include:

  • dementia
  • issues with the autonomic nervous system, such as problems with controlled movements or spasms
  • early problems with balance
  • rapid onset and progression of symptoms

Each underlying cause of Parkinsonism, such as dementia with Lewy bodies, also has its own unique set of symptoms.

Parkinsonism can be caused by Parkinson’s disease itself as well as another underlying condition.

Other causes associated with Parkinsonism include:

  • Corticobasal degeneration: This condition causes dementia as well as affected movements, usually on one side. A person may also be unable to make controlled muscle movements.
  • Dementia with Lewy bodies: This condition causes changes in overall alertness as well as visual hallucinations. This condition is the second most common cause of dementia after Alzheimer’s disease, according to Johns Hopkins Medicine.
  • Multiple system atrophy: This condition affects coordination and autonomic dysfunction, including bowel and bladder incontinence.
  • Progressive supranuclear palsy: This condition causes dementia, frequent backward falls, and problems moving the eyes up and down in addition to Parkinson’s disease symptoms.

The conditions above are the four most common causes of Parkinsonism, according to University of Texas Southwestern Medical Center. The number of people with these conditions is about one-fourth of the amount of people who have Parkinson’s disease itself.

Another, less common condition called vascular Parkinsonism also exists. This condition causes multiple, small strokes that can affect a person’s balance, walking, and memory.

Parkinsonism is also sometimes the result of taking certain medications. Doctors call this condition drug-induced Parkinsonism. Examples of drugs that could cause it include aripiprazole (Abilify), haloperidol (Haldol), and metoclopramide (Reglan).

Ideally, if a person has drug-induced Parkinsonism, they can slowly reduce the dosages of these medicines. However, that may not always be possible, and a person should not stop taking a medication without their doctor’s approval.

No single test exists for doctors to diagnose Parkinsonism.

A doctor will start by taking a person’s health history and review their current symptoms. They will ask for a medication list to determine if any medicines could be causing the symptoms.

A doctor will likely also order blood testing to check for underlying potential causes, such as thyroid or liver problems. A doctor will also order imaging scans to examine the brain and body for other causes, such as a brain tumor.

Doctors can perform a test that tracks the movement of dopamine in the brain. This is known as the DaT-SPECT test.

The test uses radioactive markers designed to track dopamine in the brain. This allows a doctor to watch the release of dopamine in a person’s brain and identify the areas of the brain that do or do not receive it.

Because Parkinsonism does not respond to typical treatments and can have a variety of symptoms, doctors can have difficulty coming to a quick diagnosis. It may take time for doctors to rule out other conditions and begin to make treatment recommendations.

One of the most commonly prescribed medications to treat Parkinson’s disease is levodopa. This medication is related to dopamine and can increase the amount of dopamine available in the brain.

However, people with Parkinsonism not only have problems producing dopamine, but they also have damaged or destroyed cells that cannot respond to dopamine. As a result, levodopa may not work as well to reduce their symptoms.

Doctors can find Parkinsonism challenging to treat because the symptoms of the condition do not always respond as well or at all to medications that boost dopamine.

As a result, treatments for Parkinsonism depend upon the “plus” disease that a person has. For example, if a person has corticobasal degeneration and related muscle spasms, a doctor may prescribe antidepressants and botulinum toxin A (BOTOX) injections.

Treatments for Parkinsonism usually aim to help reduce a person’s symptoms whenever possible to help them maintain independence. Doctors often recommend physical and occupational therapy because they can help a person keep their muscles strong and improve balance.

Source - Medical News Today